FAAH and psoriasis: Elevated levels of the two major endocannabinoids (anandamide and 2-arachidonoyl glycerol) have been observed in patients with both forms of psoriasis, despite the increased activity of enzymes degrading these endocannabinoids (e.g., fatty acid amide hydrolase and monoacylglycerol lipase) [7].